Biogen Pharmachem Industries Ltd

📋 Key Corporate Governance & Capital Updates at Biogen Pharmachem Industries Ltd

- Nominee Directors who are officers of the Corporation must have their sitting fees paid directly to the Corporation.

- The Corporation can remove or replace its appointed Directors at any time, with appointments or removals made in writing by the Chairman or Joint Chairman.

- Directors are not disqualified from contracting with the Company but must disclose any interests at Board meetings and cannot vote on related matters.

- All Directors have equal rights and privileges unless otherwise specified by the Articles or the Companies Act, 2013.

- At every annual meeting, one-third of Directors must retire by rotation, with retiring Directors eligible for re-election.

- The Board can delegate powers to Committees or Managing Directors, subject to the Companies Act, and must hold meetings at least once every 120 days.

- The Board has broad powers to manage Company business, including acquiring/disposing of property, borrowing funds, and appointing officers, subject to legal limits.

- Borrowing by the Company cannot exceed the aggregate of paid-up capital and free reserves without shareholder approval.

- Dividends can only be paid out of profits, with the Board allowed to set aside reserves before recommending dividends.

- The Company must maintain registers for Directors, mortgages, charges, and debenture holders, and comply with inspection and disclosure requirements under the Companies Act.

- The Board may refuse to register transfers of shares unless the transfer instrument is for a single class of shares.

- No fee is charged by the company for registering transfers, transmissions on death, or probate-related documents.

- Applications for sub-division or consolidation of shares into denominations less than 100 are generally not accepted, except for statutory orders, court orders, or member requests for odd lots.

- Transfers of less than 100 equity shares are not accepted, with exceptions for statutory/court orders, full transfers by small shareholders, transfers to the same transferee, or shares from bonus/rights/conversion.

- On death of a joint holder, survivors are recognized as having title; for sole holders, executors or legal representatives are recognized, with provisions for Hindu Joint Family cases.

- Persons entitled to shares due to death or insolvency may choose to be registered or transfer shares, subject to Board discretion.

- Transfers cannot be made to infants or persons of unsound mind.

- The company maintains a Register of Members and may close it for up to 45 days per year, with at least 7 days' notice.

- The company may alter capital through ordinary resolution, including increasing capital, consolidating shares, converting shares to stock, sub-dividing shares, or canceling shares.

- Capital reduction requires a special resolution and legal consent.

- Directors may accept surrender of shares as a compromise.

- Rights of share classes can be modified as per Section 48 of the Companies Act.

- Money due to shareholders may be set off against calls owed to the company.

- Fully paid shares can be converted to stock and vice versa by ordinary resolution.

- Stockholders have rights similar to shareholders, with transfer rules aligned to original shares.

- Securities can be dematerialized, with options for investors to hold certificates or use depositories; beneficial owners are treated as members.

- Annual General Meetings must be held as per Section 96, with provisions for Extraordinary General Meetings by Board or member requisition (requiring at least 1/10th of voting capital).

- Meeting notices require at least 21 days, shorter with 95% consent; quorum varies by member count (e.g., 5 for up to 1000 members).

- Voting rights: Equity shareholders vote on all resolutions; preference shareholders vote only on matters affecting their rights if dividends are unpaid for 2+ years.

- Proxies are allowed for polls, with instruments deposited 48 hours before meetings.

- Number of directors is between 3 and 15 unless changed by general meeting; no share qualification required.

- Directors receive fees for meetings and expenses; additional remuneration up to 1% of net profits may be approved by special resolution.

- Directors vacate office for reasons like unsound mind, insolvency, conviction, non-payment of calls, or absence for 12 months.

- Alternate directors can be appointed for directors absent from India for 3+ months.

- Independent directors must meet qualifications under Section 149 and listing agreements; one woman director is required.

- Key managerial personnel (e.g., CEO, CFO) can be appointed and removed by the Board.

- Additional directors hold office until the next AGM; debenture or nominee directors may be appointed by trustees or financiers under specific conditions.

- The company's authorized share capital is Rs. 1,08,00,00,000 (One Hundred Eight Crores) divided into equity shares of Rs. 1 each.

- The company's business scope includes hospitality services (hotels, lodging, guides), agriculture (farming, dairy, crop production), real estate development (land, properties, townships), manufacturing (electronics, machinery, batteries), and trading (automobiles, metals, consumer goods).

- The Articles of Association outline share issuance rules, allowing shares to be issued at par, premium, or discount, with provisions for rights variation, forfeiture, and transfer procedures.

- Subscribers include Pinakin R. Shah, Ipti P. Shah, Mahesh R. Shah, Shashikant D. Shah, Paresh A. Joshi, Hitesh R. Bhatt, and Jignasha Shah, each taking 100 equity shares.

- The company has provisions for paying commissions on share subscriptions (up to 5% for shares, 2.5% for debentures) and brokerage as permitted by law.

- Share certificates must be issued within specified timeframes post-allotment or transfer, with rules for renewal, splitting, and consolidation.

- The Board has discretion to refuse share transfers without assigning reasons, subject to appeal rights under the Companies Act.

- Lien enforcement allows the company to sell shares for unpaid calls or instalments after a 14-day notice period.

- Forfeiture of shares is permitted for non-payment of calls, with liability for unpaid amounts persisting even after forfeiture.

- The Articles incorporate regulations from Table F of the Companies Act, 2013, unless specifically modified or excluded.

- Members approved special resolutions via postal ballot dated March 23, 2026, to issue bonus shares and increase the company's authorized share capital.

- The authorized capital increase will lead to an alteration in the Capital Clause of the Memorandum of Association (MOA) of Biogen Pharmachem Industries Limited.

- The company's registered office is in Gujarat, and its main business includes manufacturing pharmaceuticals, chemicals, healthcare products, and engaging in e-commerce and data processing.

- The announcement references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015 (Regulation 30).

- Historical name changes are noted: originally Premier Fincaps Limited (incorporated July 13, 1995), later renamed Wellworth Overseas Limited (January 16, 1998), then Sun Techno Overseas Limited (May 20, 2011), and currently Biogen Pharmachem Industries Limited.